Wednesday 27th May 2015 marked the first day of the EATRIS Building Bridges in Translational Medicine conference where leading experts called for closer industry-academia collaboration.
28 May, 2015
Map of Alliances will catalogue the complex world of life science collaborations
23 May, 2015
Chemists at The Scripps Research Institute (TSRI) have discovered a broad and strikingly inexpensive method for synthesizing “amines,” a class of organic compounds prominent in drugs and other modern products.
22 May, 2015
BioTrinity 2015 hosted nearly 950 executives and investors from the life science sector
21 May, 2015
Reliable cognitive measures for patients with Alzheimer's disease are essential when testing potential new drug interventions. The high attrition rate in Alzheimer’s disease clinical trials highlights the need for more sensitive analytical tools to be used throughout the drug development process. Global science and technology company Cambridge Cognition has made a significant advancement towards this goal; today announcing a powerful new cognitive assessment product that brings efficacy testing of Alzheimer’s treatments into the digital age.
20 May, 2015
The topic of this month’s newsletter from Drug Discovery Today is Biotherapeutics
20 May, 2015
Scientists at The Scripps Research Institute (TSRI) have found using animal models that the new recreational drug alpha-PVP (“flakka”) seems equivalently potent as a stimulant, and therefore as addictive, as its chemical cousin MDPV (“bath salts”).
20 May, 2015
A new study led by scientists at The Scripps Research Institute (TSRI) sheds light on the cause of some cancers, including breast cancer and leukemia.
19 May, 2015
A bill which could make it easier to secure licences for off-patent drugs will open up market opportunities but companies will need to tread carefully, according to intellectual property firm Withers & Rogers.
11 May, 2015
A team led by scientists at The Scripps Research Institute (TSRI) and Johns Hopkins University School of Medicine has uncovered a big clue to how bacteria may promote some colon cancers.
08 May, 2015
Professor Alan Boyd, owner of Boyd's consultancy business, has been elected as President of the Faculty of Pharmaceutical Medicine. Professor Boyd, who is currently Vice President of the Faculty, will take up office on 19th November 2015.
01 May, 2015